United Capital Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64M Buy
9,403
+1,275
+16% +$473K 0.02% 447
2026
Q1
$2.38M Sell
8,128
-636
-7% -$209K 0.01% 512
2025
Q4
$3.07M Buy
8,764
+155
+2% +$52.4K 0.02% 442
2025
Q3
$2.78M Sell
8,609
-1,207
-12% -$375K 0.02% 397
2025
Q2
$3.82M Buy
9,816
+2,659
+37% +$1.07M 0.03% 315
2025
Q1
$3.11M Buy
7,157
+1,061
+17% +$426K 0.03% 348
2024
Q4
$2.25M Sell
6,096
-1,379
-18% -$577K 0.02% 400
2024
Q3
$3.89M Sell
7,475
-236
-3% -$126K 0.03% 304
2024
Q2
$4.18M Buy
7,711
+146
+2% +$77.2K 0.04% 290
2024
Q1
$3.92M Sell
7,565
-145
-2% -$72.1K 0.03% 315
2023
Q4
$3.64M Buy
7,710
+5,433
+239% +$2.51M 0.03% 328
2023
Q3
$992K Sell
2,277
-449
-16% -$204K 0.01% 516
2023
Q2
$1.21M Sell
2,726
-406
-13% -$187K 0.01% 511
2023
Q1
$1.44M Sell
3,132
-1,593
-34% -$758K 0.01% 503
2022
Q4
$2.42M Sell
4,725
-480
-9% -$244K 0.01% 444
2022
Q3
$2.36M Buy
5,205
+89
+2% +$42.6K 0.01% 446
2022
Q2
$2.47M Sell
5,116
-3,506
-41% -$1.73M 0.01% 456
2022
Q1
$4.24M Sell
8,622
-93
-1% -$42.5K 0.02% 392
2021
Q4
$4.04M Buy
8,715
+21
+0.2% +$8.84K 0.02% 407
2021
Q3
$3.24M Buy
8,694
+37
+0.4% +$14.1K 0.02% 444
2021
Q2
$3.31M Buy
8,657
+25
+0.3% +$9.55K 0.02% 441
2021
Q1
$3.1M Sell
8,632
-161
-2% -$51.8K 0.02% 428
2020
Q4
$2.82M Sell
8,793
-2,005
-19% -$615K 0.02% 445
2020
Q3
$2.9M Buy
10,798
+2,476
+30% +$666K 0.02% 428
2020
Q2
$2.19M Sell
8,322
-121
-1% -$32.3K 0.02% 496
2020
Q1
$1.92M Sell
8,443
-611
-7% -$167K 0.02% 504
2019
Q4
$2.73M Sell
9,054
-1,345
-13% -$370K 0.02% 539
2019
Q3
$2.5M Sell
10,399
-1,047
-9% -$287K 0.02% 543
2019
Q2
$3.23M Sell
11,446
-463
-4% -$126K 0.02% 504
2019
Q1
$3.42M Buy
11,909
+888
+8% +$257K 0.02% 482
2018
Q4
$2.89M Sell
11,021
-292
-3% -$80.3K 0.02% 476
2018
Q3
$3.1M Sell
11,313
-77
-0.7% -$20K 0.02% 520
2018
Q2
$2.71M Buy
11,390
+9
+0.1% +$2.08K 0.02% 526
2018
Q1
$2.5M Sell
11,381
-246
-2% -$57.8K 0.02% 533
2017
Q4
$2.62M Sell
11,627
-574
-5% -$122K 0.02% 529
2017
Q3
$2.32M Buy
12,201
+2,866
+31% +$545K 0.02% 539
2017
Q2
$1.76M Sell
9,335
-577
-6% -$104K 0.02% 612
2017
Q1
$1.64M Sell
9,912
-220
-2% -$35K 0.02% 613
2016
Q4
$1.46M Sell
10,132
-941
-8% -$126K 0.01% 635
2016
Q3
$1.39M Buy
11,073
+1,886
+21% +$244K 0.01% 688
2016
Q2
$1.2M Buy
9,187
+327
+4% +$44.7K 0.01% 681
2016
Q1
$1.23M Sell
8,860
-2,729
-24% -$365K 0.01% 651
2015
Q4
$1.62M Buy
11,589
+3,227
+39% +$445K 0.02% 586
2015
Q3
$1.17M Buy
8,362
+281
+3% +$42.2K 0.01% 650
2015
Q2
$1.33M Sell
8,081
-618
-7% -$98.7K 0.02% 674
2015
Q1
$1.31M Buy
8,699
+2,704
+45% +$385K 0.02% 669
2014
Q4
$753K Buy
5,995
+1,123
+23% +$139K 0.01% 708
2014
Q3
$583K Buy
+4,872
New +$559K 0.01% 752
2014
Q2
Sell
-4,301
Closed -$428K 830
2014
Q1
$428K Buy
4,301
+21
+0.5% +$1.9K 0.01% 667
2013
Q4
$395K Hold
4,280
0.01% 466
2013
Q3
$358K Buy
4,280
+29
+0.7% +$2.48K 0.01% 519
2013
Q2
$348K Buy
+4,251
New +$318K 0.01% 571

Other funds holding ELV

United Capital Financial Advisors's ELV Position: Q2 2026 in Review

United Capital Financial Advisors increased its Elevance Health (ELV) stake by 16% in Q2 2026, buying an estimated $473K and bringing the position to 9,403 shares worth $3.64M. The position accounts for 0.02% of the portfolio, ranked #447.

United Capital Financial Advisors first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.24M in Q1 2022. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • United Capital Financial Advisors held 9,403 shares of Elevance Health worth $3.64M as of Q2 2026.
  • United Capital Financial Advisors bought 1,275 Elevance Health shares in Q2 2026, an estimated $473K.
  • Elevance Health made up 0.02% of United Capital Financial Advisors's portfolio in Q2 2026, its #447 holding.
  • United Capital Financial Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Elevance Health position peaked at $4.24M in Q1 2022.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.